MENU
CNCR
ETF ticker:
PRICE
CHANGE
NET ASSETS

Range Cancer Therapeutics ETF (CNCR) Ownership - Who owns Range Cancer Therapeutics ETF?

Profile

Category
Health
Address
ETF Series Solutions615 East Michigan Street, Milwaukee, WisconsinEast Michigan
Phone
(414) 765-5586
Web
N/A

Details

Group
Alternative Funds
Category
Unknown
Net Assets
6946185.00
Fund Existence
over 9 years
Turnover
52.00
Capitalization
N/A
Yield
N/A
Total Expense Ratio
0.79
Investment Style
N/A
Risk (Beta)
0.96

Fundamentals

CNCR
Net Assets
6.95M
Yield
0.00
Fund Existence
over 9 years
Total Expense Ratio
0.79
Turnover
52.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
0.96
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
0.79
Assets in Top Ten Holdings
4.2M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
6.95M
Fund Type
ETF
Index Fund
Yes
Management Fee
0.79
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
67.00
Number of Net Holdings
68.00
Number of Short Holdings
1.00
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
19.14%
Gain YTD
-26.726
View a ticker or compare two or three
CNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Unknown

Profile
Fundamentals
Details
Category
Health
Address
ETF Series Solutions615 East Michigan Street, Milwaukee, WisconsinEast Michigan
Phone
(414) 765-5586
Web
N/A